Text Size

Recovery Group Pilot

This study has been completed.
Sponsor:
Collaborators:
Portland State University
University of South Florida
Information provided by:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT00522613
First received: August 29, 2007
Last updated: February 3, 2009
Last verified: September 2006
History of Changes
  Purpose

The purpose of this study is to develop and evaluate a low-cost, joint consumer/counselor-led, health education and support intervention that will foster self-care and recovery among adults with serious mental illness. Results from the study will indicate how well the workbook and the overall program were received by individuals with serious mental illness, and whether participating in the program appeared to improve recovery and functioning.


Condition Intervention
Bipolar Disorder
Schizophrenia
Schizoaffective Disorder
 Behavioral: Recovery Group Project

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Recovery Group Pilot

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • To develop group-facilitator materials to complement the self-help workbook [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
  • To conduct a randomized trial of the intervention with KPNW members [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
  • To assess participant attendance and satisfaction with the group sessions [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
  • To assess whether participating in the group intervention was associated with improvements in short-term recovery and functioning [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]

Enrollment: 50
Study Start Date: July 2005
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Recovery Group Project
    Recovery Group Workbook & Group Sessions
Detailed Description:

Recent research suggests that many individuals with serious mental illnesses may recover from these conditions and become fully integrated into their communities. Although improved medications may be most responsible for these developments, self-help groups, social support, and empowerment have been identified as important facilitators of the recovery process. Recovery-oriented, consumer-led approaches are gaining in popularity, but few of these interventions have been evaluated scientifically.

This pilot study proposes to develop and evaluate a recovery-oriented program that centers on the use of a self-help workbook. Results from the study will indicate how well the workbook and the overall program were received by individuals with serious mental illness, and whether participating in the program appeared to improve recovery and functioning.

Objectives:

  1. To develop group-facilitator materials to complement the self-help workbook.
  2. To conduct a randomized trial of the intervention with kaiser Permanente Northwest (KPNW) members with bipolar disorder or schizophrenia/schizoaffective disorder, using a delayed control group design and 6- and 12-month post-intervention follow-up.
  3. To assess participant attendance and satisfaction with the group sessions;
  4. To assess whether participating in the group intervention was associated with improvements in short-term recovery and functioning.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of bipolar disorder or schizophrenia/schizoaffective disorder
  • current membership in KPNW
  • age 18 or over

Exclusion Criteria:

  • having a guardian
  • psychotic symptoms that interfere with group interactions
  • dementia, mental retardation (other than mild) or other organic brain conditions that affect an individual's ability to participate in an interview, a group intervention, or complete questionnaires
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00522613

Locations
United States, Oregon
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227
Sponsors and Collaborators
Kaiser Permanente
Portland State University
University of South Florida
Investigators
Principal Investigator: Carla A. Green, PhD, MPH Kaiser Permanente
  More Information

No publications provided

Responsible Party: Stanley Watson, Kaiser Foundation Research Institute
ClinicalTrials.gov Identifier: NCT00522613     History of Changes
Other Study ID Numbers: NW-05CGREE-01
Study First Received: August 29, 2007
Last Updated: February 3, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
recovery
serious mental illness
bipolar disorder
schizophrenia
schizoaffective disorder

Additional relevant MeSH terms:
Bipolar Disorder
Psychotic Disorders
Schizophrenia
Affective Disorders, Psychotic
 Mood Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on May 19, 2013